These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 33888767)

  • 1. Vegfa promoter gene hypermethylation at HIF1α binding site is an early contributor to CKD progression after renal ischemia.
    Sánchez-Navarro A; Pérez-Villalva R; Murillo-de-Ozores AR; Martínez-Rojas MÁ; Rodríguez-Aguilera JR; González N; Castañeda-Bueno M; Gamba G; Recillas-Targa F; Bobadilla NA
    Sci Rep; 2021 Apr; 11(1):8769. PubMed ID: 33888767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A short treatment with resveratrol after a renal ischaemia-reperfusion injury prevents maladaptive repair and long-term chronic kidney disease in rats.
    Martínez-Rojas MÁ; Balcázar H; Ponce-Nava MS; González-Soria I; Marquina-Castillo B; Pérez-Villalva R; Bobadilla NA
    J Physiol; 2024 Apr; 602(8):1835-1852. PubMed ID: 38529522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gender Differences in the Acute Kidney Injury to Chronic Kidney Disease Transition.
    Lima-Posada I; Portas-Cortés C; Pérez-Villalva R; Fontana F; Rodríguez-Romo R; Prieto R; Sánchez-Navarro A; Rodríguez-González GL; Gamba G; Zambrano E; Bobadilla NA
    Sci Rep; 2017 Sep; 7(1):12270. PubMed ID: 28947737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathophysiology of unilateral ischemia-reperfusion injury: importance of renal counterbalance and implications for the AKI-CKD transition.
    Polichnowski AJ; Griffin KA; Licea-Vargas H; Lan R; Picken MM; Long J; Williamson GA; Rosenberger C; Mathia S; Venkatachalam MA; Bidani AK
    Am J Physiol Renal Physiol; 2020 May; 318(5):F1086-F1099. PubMed ID: 32174143
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed spironolactone administration prevents the transition from acute kidney injury to chronic kidney disease through improving renal inflammation.
    Barrera-Chimal J; Rocha L; Amador-Martínez I; Pérez-Villalva R; González R; Cortés-González C; Uribe N; Ramírez V; Berman N; Gamba G; Bobadilla NA
    Nephrol Dial Transplant; 2019 May; 34(5):794-801. PubMed ID: 30107561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AT1 receptor antagonism before ischemia prevents the transition of acute kidney injury to chronic kidney disease.
    Rodríguez-Romo R; Benítez K; Barrera-Chimal J; Pérez-Villalva R; Gómez A; Aguilar-León D; Rangel-Santiago JF; Huerta S; Gamba G; Uribe N; Bobadilla NA
    Kidney Int; 2016 Feb; 89(2):363-73. PubMed ID: 26509589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKI on CKD: heightened injury, suppressed repair, and the underlying mechanisms.
    He L; Wei Q; Liu J; Yi M; Liu Y; Liu H; Sun L; Peng Y; Liu F; Venkatachalam MA; Dong Z
    Kidney Int; 2017 Nov; 92(5):1071-1083. PubMed ID: 28890325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-195-5p alleviates acute kidney injury through repression of inflammation and oxidative stress by targeting vascular endothelial growth factor A.
    Xu Y; Jiang W; Zhong L; Li H; Bai L; Chen X; Lin Y; Zheng D
    Aging (Albany NY); 2020 Jun; 12(11):10235-10245. PubMed ID: 32492657
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-anemia drug FG4592 retards the AKI-to-CKD transition by improving vascular regeneration and antioxidative capability.
    Wu M; Chen W; Miao M; Jin Q; Zhang S; Bai M; Fan J; Zhang Y; Zhang A; Jia Z; Huang S
    Clin Sci (Lond); 2021 Jul; 135(14):1707-1726. PubMed ID: 34255035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression of Chronic Kidney Disease After Acute Kidney Injury: Role of Self-Perpetuating Versus Hemodynamic-Induced Fibrosis.
    Picken M; Long J; Williamson GA; Polichnowski AJ
    Hypertension; 2016 Oct; 68(4):921-8. PubMed ID: 27550923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypoxia as a key player in the AKI-to-CKD transition.
    Tanaka S; Tanaka T; Nangaku M
    Am J Physiol Renal Physiol; 2014 Dec; 307(11):F1187-95. PubMed ID: 25350978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypoxia inducible factor stabilization improves defective ischemia-induced angiogenesis in a rodent model of chronic kidney disease.
    Schellinger IN; Cordasic N; Panesar J; Buchholz B; Jacobi J; Hartner A; Klanke B; Jakubiczka-Smorag J; Burzlaff N; Heinze E; Warnecke C; Raaz U; Willam C; Tsao PS; Eckardt KU; Amann K; Hilgers KF
    Kidney Int; 2017 Mar; 91(3):616-627. PubMed ID: 27927598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Poricoic acid A enhances melatonin inhibition of AKI-to-CKD transition by regulating Gas6/AxlNFκB/Nrf2 axis.
    Chen DQ; Feng YL; Chen L; Liu JR; Wang M; Vaziri ND; Zhao YY
    Free Radic Biol Med; 2019 Apr; 134():484-497. PubMed ID: 30716432
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-acetyl-cysteine increases cellular dysfunction in progressive chronic kidney damage after acute kidney injury by dampening endogenous antioxidant responses.
    Small DM; Sanchez WY; Roy SF; Morais C; Brooks HL; Coombes JS; Johnson DW; Gobe GC
    Am J Physiol Renal Physiol; 2018 May; 314(5):F956-F968. PubMed ID: 29357409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methylation in pericytes after acute injury promotes chronic kidney disease.
    Chou YH; Pan SY; Shao YH; Shih HM; Wei SY; Lai CF; Chiang WC; Schrimpf C; Yang KC; Lai LC; Chen YM; Chu TS; Lin SL
    J Clin Invest; 2020 Sep; 130(9):4845-4857. PubMed ID: 32749240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular communication network factor 2 (CCN2) promotes the progression of acute kidney injury to chronic kidney disease.
    Inoue T; Kusano T; Amano H; Nakamoto H; Okada H
    Biochem Biophys Res Commun; 2019 Sep; 517(1):96-102. PubMed ID: 31320136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic Changes in the Acute Kidney Injury-to-Chronic Kidney Disease Transition.
    Nangaku M; Hirakawa Y; Mimura I; Inagi R; Tanaka T
    Nephron; 2017; 137(4):256-259. PubMed ID: 28595179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant Long-Acting Thioredoxin Ameliorates AKI to CKD Transition via Modulating Renal Oxidative Stress and Inflammation.
    Nishida K; Watanabe H; Murata R; Tokumaru K; Fujimura R; Oshiro S; Nagasaki T; Miyahisa M; Hiramoto Y; Nosaki H; Imafuku T; Maeda H; Fukagawa M; Maruyama T
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34070521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-dose hydralazine prevents fibrosis in a murine model of acute kidney injury-to-chronic kidney disease progression.
    Tampe B; Steinle U; Tampe D; Carstens JL; Korsten P; Zeisberg EM; Müller GA; Kalluri R; Zeisberg M
    Kidney Int; 2017 Jan; 91(1):157-176. PubMed ID: 27692563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Spironolactone prevents chronic kidney disease caused by ischemic acute kidney injury.
    Barrera-Chimal J; Pérez-Villalva R; Rodríguez-Romo R; Reyna J; Uribe N; Gamba G; Bobadilla NA
    Kidney Int; 2013 Jan; 83(1):93-103. PubMed ID: 23014458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.